Biopharm is under pressure to perform clinical trials more efficiently. To support these efforts Oracle has been organically and inorganically strengthening its life science software suite, most recently with the introduction of Clinical Development Analytics 2.0 and Data Hub 2.1.4.
“Life sciences organisations are increasingly focused on improving operational efficiency and productivity across the discovery and development phases to improve the overall performance of their programmes”, said Neil de Crescenzo, senior vice president, Oracle Health Sciences.
Introduction of Clinical Development Analytics 2.0 builds on the software’s original focus on data management to provide rich content for clinical operations. The software includes more than 360 pre-built and pre-sourced metrics to provide insight into trial performance.
Oracle claims the software helps: boost trial efficiency by giving insight into screening, recruitment and retention; identify bottlenecks at low performing sites and regions; detect barriers to cut start up times; and accelerate database lock.
Data used by the analytics software is sourced directly from Oracle’s Siebel Clinical Trial Management System, as well as the company’s Clinical and Remote Data Capture packages.
Launch of Clinical Development Analytics 2.0 was accompanied by introduction of Data Hub 2.1.4. Using Data Hub 2.1.4 biopharm can integrate clinical, non-clinical and safety data from multiple sources into a single, validated and secure repository.
Collating data into a single repository helps biopharm streamline business processes related to the acquisition, analysis and reporting of clinical trial data. Biopharm can use the platform to increase research efficiency, simplify regulatory compliance and inform decision making.
Oracle claims version 2.1.4: boosts productivity by improving usability, for instance by simplifying submission processes; expands business intelligence capabilities to provide greater insight; and streamlines data integration.